APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiological Protein (Gaprin)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microbiological Protein (Gaprin) Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchMicrobiological Protein (Gaprin) Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiological Protein (Gaprin) Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Microbiological Protein (Gaprin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiological Protein (Gaprin) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbiological Protein (Gaprin) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Microbiological Protein (Gaprin) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microbiological Protein (Gaprin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbiological Protein (Gaprin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbiological Protein (Gaprin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microbiological Protein (Gaprin) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microbiological Protein (Gaprin) market include Unibio, Prtotelux, Metanica, Giprobiosyntez and Calysta, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microbiological Protein (Gaprin) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbiological Protein (Gaprin) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbiological Protein (Gaprin) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microbiological Protein (Gaprin) market.

Microbiological Protein (Gaprin) Segment by Company

Unibio

Prtotelux

Metanica

Giprobiosyntez

Calysta

Microbiological Protein (Gaprin) Segment by Type

Food Grade

Feed Grade

Microbiological Protein (Gaprin) Segment by Application

Food & Beverages

Animal Feed

Others

Microbiological Protein (Gaprin) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Microbiological Protein (Gaprin) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microbiological Protein (Gaprin) key companies, revenue, market share, and recent developments.

3. To split the Microbiological Protein (Gaprin) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microbiological Protein (Gaprin) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microbiological Protein (Gaprin) significant trends, drivers, influence factors in global and regions.

6. To analyze Microbiological Protein (Gaprin) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiological Protein (Gaprin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiological Protein (Gaprin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiological Protein (Gaprin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiological Protein (Gaprin) industry.

Chapter 3: Detailed analysis of Microbiological Protein (Gaprin) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microbiological Protein (Gaprin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microbiological Protein (Gaprin) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microbiological Protein (Gaprin) Industry Trends Table 2. Microbiological Protein (Gaprin) Industry Drivers Table 3. Microbiological Protein (Gaprin) Industry Opportunities and Challenges Table 4. Microbiological Protein (Gaprin) Industry Restraints Table 5. Global Microbiological Protein (Gaprin) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microbiological Protein (Gaprin) Revenue Share by Company (2021-2026) Table 7. Global Microbiological Protein (Gaprin) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microbiological Protein (Gaprin) Key Company Manufacturing Base & Headquarters Table 9. Global Microbiological Protein (Gaprin) Company, Product Type & Application Table 10. Global Microbiological Protein (Gaprin) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microbiological Protein (Gaprin) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Food Grade Table 15. Significant Companies of Feed Grade Table 16. Global Microbiological Protein (Gaprin) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Microbiological Protein (Gaprin) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Microbiological Protein (Gaprin) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Microbiological Protein (Gaprin) Sales Value Share by Type (2021-2026) Table 20. Global Microbiological Protein (Gaprin) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Food & Beverages Table 22. Significant Companies of Animal Feed Table 23. Significant Companies of Others Table 24. Global Microbiological Protein (Gaprin) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Microbiological Protein (Gaprin) Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Microbiological Protein (Gaprin) Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Microbiological Protein (Gaprin) Sales Value Share by Application (2021-2026) Table 28. Global Microbiological Protein (Gaprin) Sales Value Share by Application (2027-2032) Table 29. Global Microbiological Protein (Gaprin) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Microbiological Protein (Gaprin) Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Microbiological Protein (Gaprin) Sales Value Share by Region (2021-2026) Table 32. Global Microbiological Protein (Gaprin) Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Microbiological Protein (Gaprin) Sales Value Share by Region (2027-2032) Table 34. Global Microbiological Protein (Gaprin) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Microbiological Protein (Gaprin) Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Microbiological Protein (Gaprin) Sales Value Market Share by Country (2021-2026) Table 37. Global Microbiological Protein (Gaprin) Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Microbiological Protein (Gaprin) Sales Value Market Share by Country (2027-2032) Table 39. Unibio Company Information Table 40. Unibio Business Overview Table 41. Unibio Microbiological Protein (Gaprin) Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Unibio Microbiological Protein (Gaprin) Product Portfolio Table 43. Unibio Recent Development Table 44. Prtotelux Company Information Table 45. Prtotelux Business Overview Table 46. Prtotelux Microbiological Protein (Gaprin) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Prtotelux Microbiological Protein (Gaprin) Product Portfolio Table 48. Prtotelux Recent Development Table 49. Metanica Company Information Table 50. Metanica Business Overview Table 51. Metanica Microbiological Protein (Gaprin) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Metanica Microbiological Protein (Gaprin) Product Portfolio Table 53. Metanica Recent Development Table 54. Giprobiosyntez Company Information Table 55. Giprobiosyntez Business Overview Table 56. Giprobiosyntez Microbiological Protein (Gaprin) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Giprobiosyntez Microbiological Protein (Gaprin) Product Portfolio Table 58. Giprobiosyntez Recent Development Table 59. Calysta Company Information Table 60. Calysta Business Overview Table 61. Calysta Microbiological Protein (Gaprin) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Calysta Microbiological Protein (Gaprin) Product Portfolio Table 63. Calysta Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Microbiological Protein (Gaprin) Product Image Figure 2. Global Microbiological Protein (Gaprin) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbiological Protein (Gaprin) Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbiological Protein (Gaprin) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Food Grade Image Figure 8. Feed Grade Image Figure 9. Global Microbiological Protein (Gaprin) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Microbiological Protein (Gaprin) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Microbiological Protein (Gaprin) Sales Value Share by Type (2021-2032) Figure 12. Food & Beverages Image Figure 13. Animal Feed Image Figure 14. Others Image Figure 15. Global Microbiological Protein (Gaprin) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Microbiological Protein (Gaprin) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Microbiological Protein (Gaprin) Sales Value Share by Application (2021-2032) Figure 18. Global Microbiological Protein (Gaprin) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Microbiological Protein (Gaprin) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Microbiological Protein (Gaprin) Sales Value (2021-2032) & (US$ Million) Figure 21. North America Microbiological Protein (Gaprin) Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Microbiological Protein (Gaprin) Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Microbiological Protein (Gaprin) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Microbiological Protein (Gaprin) Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Microbiological Protein (Gaprin) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Microbiological Protein (Gaprin) Sales Value (2021-2032) & (US$ Million) Figure 27. South America Microbiological Protein (Gaprin) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Microbiological Protein (Gaprin) Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Microbiological Protein (Gaprin) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Feed Grade
Applications
  • Food & Beverages
  • Animal Feed
  • Others
Companies covered
  • Unibio
  • Prtotelux
  • Metanica
  • Giprobiosyntez
  • Calysta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbiological Protein (Gaprin) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbiological Protein (Gaprin) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microbiological Protein (Gaprin) Market Dynamics
  1. 2.1 Microbiological Protein (Gaprin) Industry Trends
  2. 2.2 Microbiological Protein (Gaprin) Industry Drivers
  3. 2.3 Microbiological Protein (Gaprin) Industry Opportunities and Challenges
  4. 2.4 Microbiological Protein (Gaprin) Industry Restraints
3 Microbiological Protein (Gaprin) Market by Company
  1. 3.1 Global Microbiological Protein (Gaprin) Company Revenue Ranking in 2025
  2. 3.2 Global Microbiological Protein (Gaprin) Revenue by Company (2021-2026)
  3. 3.3 Global Microbiological Protein (Gaprin) Company Ranking (2024-2026)
  4. 3.4 Global Microbiological Protein (Gaprin) Company Manufacturing Base and Headquarters
  5. 3.5 Global Microbiological Protein (Gaprin) Company Product Type and Application
  6. 3.6 Global Microbiological Protein (Gaprin) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microbiological Protein (Gaprin) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microbiological Protein (Gaprin) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microbiological Protein (Gaprin) Market by Type
  1. 4.1 Microbiological Protein (Gaprin) Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Feed Grade
  4. 4.2 Global Microbiological Protein (Gaprin) Sales Value by Type
  5. 4.2.1 Global Microbiological Protein (Gaprin) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Microbiological Protein (Gaprin) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Microbiological Protein (Gaprin) Sales Value Share by Type (2021-2032)
5 Microbiological Protein (Gaprin) Market by Application
  1. 5.1 Microbiological Protein (Gaprin) Application Introduction
  2. 5.1.1 Food & Beverages
  3. 5.1.2 Animal Feed
  4. 5.1.3 Others
  5. 5.2 Global Microbiological Protein (Gaprin) Sales Value by Application
  6. 5.2.1 Global Microbiological Protein (Gaprin) Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microbiological Protein (Gaprin) Sales Value by Application (2021-2032)
  8. 5.2.3 Global Microbiological Protein (Gaprin) Sales Value Share by Application (2021-2032)
6 Microbiological Protein (Gaprin) Regional Value Analysis
  1. 6.1 Global Microbiological Protein (Gaprin) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbiological Protein (Gaprin) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microbiological Protein (Gaprin) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microbiological Protein (Gaprin) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbiological Protein (Gaprin) Sales Value (2021-2032)
  7. 6.3.2 North America Microbiological Protein (Gaprin) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microbiological Protein (Gaprin) Sales Value (2021-2032)
  10. 6.4.2 Europe Microbiological Protein (Gaprin) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microbiological Protein (Gaprin) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microbiological Protein (Gaprin) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microbiological Protein (Gaprin) Sales Value (2021-2032)
  16. 6.6.2 South America Microbiological Protein (Gaprin) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microbiological Protein (Gaprin) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microbiological Protein (Gaprin) Sales Value Share by Country, 2025 VS 2032
7 Microbiological Protein (Gaprin) Country-level Value Analysis
  1. 7.1 Global Microbiological Protein (Gaprin) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microbiological Protein (Gaprin) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microbiological Protein (Gaprin) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microbiological Protein (Gaprin) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microbiological Protein (Gaprin) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microbiological Protein (Gaprin) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microbiological Protein (Gaprin) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Unibio
  2. 8.1.1 Unibio Company Information
  3. 8.1.2 Unibio Business Overview
  4. 8.1.3 Unibio Microbiological Protein (Gaprin) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Unibio Microbiological Protein (Gaprin) Product Portfolio
  6. 8.1.5 Unibio Recent Developments
  7. 8.2 Prtotelux
  8. 8.2.1 Prtotelux Company Information
  9. 8.2.2 Prtotelux Business Overview
  10. 8.2.3 Prtotelux Microbiological Protein (Gaprin) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Prtotelux Microbiological Protein (Gaprin) Product Portfolio
  12. 8.2.5 Prtotelux Recent Developments
  13. 8.3 Metanica
  14. 8.3.1 Metanica Company Information
  15. 8.3.2 Metanica Business Overview
  16. 8.3.3 Metanica Microbiological Protein (Gaprin) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Metanica Microbiological Protein (Gaprin) Product Portfolio
  18. 8.3.5 Metanica Recent Developments
  19. 8.4 Giprobiosyntez
  20. 8.4.1 Giprobiosyntez Company Information
  21. 8.4.2 Giprobiosyntez Business Overview
  22. 8.4.3 Giprobiosyntez Microbiological Protein (Gaprin) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Giprobiosyntez Microbiological Protein (Gaprin) Product Portfolio
  24. 8.4.5 Giprobiosyntez Recent Developments
  25. 8.5 Calysta
  26. 8.5.1 Calysta Company Information
  27. 8.5.2 Calysta Business Overview
  28. 8.5.3 Calysta Microbiological Protein (Gaprin) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Calysta Microbiological Protein (Gaprin) Product Portfolio
  30. 8.5.5 Calysta Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst